Form 4 AEHR TEST SYSTEMS For: Oct 02 Filed by: RICHMOND DONALD P. II
This SEC Form 4 filing indicates changes in beneficial ownership of AEHR TEST SYSTEMS (AEHR) stock by Donald P. Richmond II, the company's CTO. On October 2, 2026, 439 shares were withheld to satisfy tax withholding obligations upon the vesting of restricted stock units at a price of $107.21 per share. Following this transaction, Richmond beneficially owns 187,116 shares, which includes shares subject to unvested restricted stock units.
CTO acquires shares at $6.6725 under Aehr Test Systems (AEHR)'s employee stock purchase plan.
Aehr Test Systems' CTO, Donald P. Richmond II, acquired 1,064 common shares on October 1, 2026, through the company's employee stock purchase plan at $6.6725 per share. On the same date, 76 shares were withheld to cover tax obligations from vested restricted stock units, valued at $101.60 per share, which is not considered a sale. This activity indicates an increase in the CTO's direct holdings to 187,555 shares.
A COO acquires 730 shares at AEHR Test Systems (AEHR); 98 shares are withheld for taxes, not sold.
Adil Engineer, the Chief Operating Officer of AEHR Test Systems, acquired 730 common shares through an Employee Stock Purchase Plan at $6.6725 per share on October 1, 2026. Concurrently, 98 shares were withheld to cover tax obligations related to the vesting of restricted stock units, which was not a sale. Following these transactions, Engineer's direct holdings in common stock total 47,109 shares.
An employee-plan purchase adds 1,221 shares for AEHR Test Systems (AEHR) VP Alistair N. Sporck.
Alistair N. Sporck, VP of Contactor Business Unit at AEHR Test Systems (AEHR), reported two transactions on October 1, 2026. He had 54 shares withheld for tax obligations from restricted stock unit vesting and separately purchased 1,221 shares through the company’s Amended and Restated 2006 Employee Stock Purchase Plan at $6.6725 per share. The employee-plan purchase is exempt from Section 16 short-swing liability.
Form 4 Aehr Test Systems For: 1 October By Investing.com
The article reports on a Form 4 filing for Aehr Test Systems (AEHR) dated October 1. A Form 4 is a document that must be filed with the U.S. Securities and Exchange Commission (SEC) whenever there is a material change in the holdings of company insiders. The filing likely details transactions by company officers, directors, or beneficial owners.
Aehr Test Systems CFO Chris Siu Reports Two Stock Transactions on October 1, 2026
Aehr Test Systems CFO Chris Siu conducted two stock transactions on October 1, 2026. These included the disposal of 194 shares for tax withholding purposes at $101.6 per share and the acquisition of 1,089 shares at $6.6725 per share through the company's Employee Stock Purchase Plan. Following these transactions, Siu's direct ownership is 77,134 shares, and indirect ownership via a trust is 6,795 shares.
A trust acquired 1,089 Aehr Test Systems (AEHR) shares; CFO Chris Siu had 194 withheld for taxes.
Aehr Test Systems CFO Chris Siu reported two transactions on October 1, 2026. A trust indirectly acquired 1,089 shares through an employee stock purchase plan, increasing the trust's holdings to 6,795 shares. Additionally, 194 shares were withheld for tax obligations upon the vesting of restricted stock units, which was not considered a sale.
Aehr Test Systems expects strong Q3 earnings and 160-200% revenue growth in fiscal 2027 driven by AI chip demand.
Aehr Test Systems anticipates strong Q3 earnings, projecting $0.11 per share and $27 million in revenue, a significant year-over-year increase. The company forecasts 160-200% revenue growth for fiscal year 2027, driven by high demand for AI and data-center chip testing, supported by a substantial backlog. Investors are keen on the upcoming October 5 earnings report and future order trends.
AEHR TEST SYSTEMS Q1 2027 Earnings Preview: Recent $AEHR Insider Trading, Hedge Fund Activity, and More
AEHR Test Systems ($AEHR) is set to release its Q1 2027 earnings on October 1st, with analysts expecting revenues of $27.6 million and earnings of $0.11 per share. Insider trading activity over the last six months shows 61 sales and no purchases, with significant sales by top executives. Hedge fund activity indicates a mixed sentiment, with 172 institutional investors adding shares and 109 decreasing their positions in Q2 2026.
Aehr Test Systems shares may move 8.4% on earnings release
Aehr Test Systems (AEHR) shares are projected to move 8.4% upon the release of its earnings report on October 6, based on options data. The stock has historically surpassed its options-implied move in six out of the last eight earnings reports, with significant actual price changes compared to implied moves in previous quarters. The specific time of the earnings announcement has not yet been confirmed by the company.
Aehr Test Systems to Participate in 18th Annual CEO Investor Summit 2026 in San Francisco
Aehr Test Systems announced that its President and CEO, Gayn Erickson, and CFO, Chris Siu, will participate in the 18th Annual CEO Investor Summit on October 13th, 2026, in San Francisco. The company will discuss its expanding role in providing test and burn-in solutions for next-generation semiconductor devices across various markets, including AI processors, silicon carbide, and silicon photonics. This summit provides an opportunity for investors and analysts to meet with company management teams in a "round-robin" format.
Aehr Test Systems (AEHR) Set to Announce Quarterly Earnings on Monday
Aehr Test Systems (NASDAQ:AEHR) is scheduled to announce its Q1 2027 earnings after the market closes on Monday, October 5th. Analysts expect the company to report earnings of $0.11 per share and revenue of $27.04 million. The stock currently has a "Moderate Buy" consensus rating with an average price target of $132.50, although insiders have recently sold a significant number of shares.
Aehr Test Systems to Participate in 18th Annual CEO Investor Summit 2026 in San Francisco
Aehr Test Systems (NASDAQ:AEHR) announced its participation in the 18th Annual CEO Investor Summit on October 13, 2026, in San Francisco. President and CEO Gayn Erickson and CFO Chris Siu will discuss the company's expanding role in semiconductor device testing for AI, silicon photonics, data center, automotive, and industrial applications. The company highlights its turnkey solutions for improving semiconductor quality, reliability, and yield, emphasizing strong traction with AI processors and the growth of wafer-level and package-level test and burn-in.
121,056 Shares of Aehr Test Systems $AEHR Purchased by Bank of America Corp DE
Bank of America Corp DE acquired 121,056 shares of Aehr Test Systems (NASDAQ:AEHR) in the second quarter, valuing its new position at approximately $11.6 million. This purchase contributes to the 69.69% institutional ownership of the company, even as insiders have recently sold over 109,000 shares. Despite insider sales, analysts maintain a "Moderate Buy" rating for AEHR, with a consensus price target of $132.50.
State Street Corp Grows Holdings in Aehr Test Systems $AEHR
State Street Corp significantly increased its stake in Aehr Test Systems (NASDAQ:AEHR) by 14.4% in the second quarter, now owning 712,926 shares valued at $68.5 million. Other institutional investors like BlackRock and Wellington Management also expanded their positions, bringing the total institutional ownership to 69.69%. Despite positive analyst ratings with a "Moderate Buy" consensus and an average price target of $132.50, company insiders have sold a substantial amount of shares recently.
AEHR Stock Jumps As Oppenheimer Targets AI Test Boom
Aehr Test Systems (AEHR) stock jumped over 7% after Oppenheimer initiated coverage with an "Outperform" rating and a $120 price target, citing strong AI-driven demand for semiconductor test systems. The company secured a record $41M hyperscaler order for its Sonoma system and is seeing its FOX-XP platform ramp up with a major AI processor customer, pushing revenue forecasts above Street estimates. Despite a rich valuation, AEHR's strong balance sheet and position in key market trends like AI and EVs make it a momentum stock attracting significant trader attention.
Aehr Test Systems (AEHR) Following Its Rally Faces A Pricey Valuation Narrative
Aehr Test Systems (AEHR) has seen significant share price appreciation, with a 339.62% year-to-date gain and a recent close of $97.42. Despite trading about 31% below the average analyst price target, Simply Wall St's valuation model suggests AEHR is 433.2% overvalued with a fair value of $18.27, citing past dilution and insider cash-outs. The article advises investors to scrutinize the company's fundamentals and potential risks, even as positive earnings or new order cycles could challenge this overvaluation thesis.
Aehr Test Systems, ChronoScale lead mid-cap tech stocks with top momentum scores
Aehr Test Systems and ChronoScale are leading mid-cap information technology stocks with top "A+" momentum grades from Seeking Alpha, reflecting strong price performance over the past six months. Aehr Test Systems gained over 162%, while ChronoScale advanced nearly 93.49%. The article lists other mid-cap tech stocks that also received A+ momentum grades, highlighting significant gains for several of them.
RAEHR to TRY: Aehr Test Systems rStock Price in Turkish Lira
The article provides the current price of Aehr Test Systems rStock (RAEHR) in Turkish Lira (TRY) and details how to buy RAEHR with TRY on crypto exchanges. It highlights that 1 RAEHR is currently valued at ₺4,642.22, with a slight increase over the past day but a 0.0% decline in the last hour. The piece also includes historical price data for RAEHR against TRY over the past seven days, showing fluctuations and significant daily movements.
Oppenheimer initiates Aehr Test Systems stock with outperform rating
Oppenheimer has initiated coverage on Aehr Test Systems (NASDAQ:AEHR) with an outperform rating and a $120 price target, citing the company's strong position in the AI-driven semiconductor testing equipment market. The firm projects significant revenue growth for Aehr in fiscal 2027 and 2028, driven by its Sonoma and FOXXP platforms. Despite a rich valuation, Oppenheimer believes the stock has further upside potential if the FOX platform secures additional major AI processor clients.
Aehr Test Systems Insider Sells $847,000 Worth of Stock
Vernon Rogers, Executive VP of Sales & Marketing at Aehr Test Systems (NASDAQ:AEHR), sold 5,994 shares of common stock for approximately $847,000. Despite this sale, Rogers retains a significant stake of 186,232 shares valued at over $27 million, indicating it was likely a routine profit-taking move after the stock's substantial appreciation. Aehr Test Systems is benefiting from the AI boom, showing increased revenue and bookings, and analysts view the sale as a minor adjustment rather than a signal of concern.
A 9-Day Losing Streak Has Aehr Test Systems Stock Down 45%
Aehr Test Systems (AEHR) stock has experienced a 9-day losing streak, resulting in a 45% cumulative loss and a reduction of $2.1 billion in market value. This specific downturn is not reflected in the broader S&P 500, and the company's business fundamentals show declining revenue and negative operating margins. While streaks are merely information, investors are advised to re-evaluate their investment thesis rather than reacting solely to the momentum.
Aehr Test Systems (AEHR) Faces A Fresh Valuation Debate As Conference Appearances Near
Aehr Test Systems (AEHR) is gaining attention due to upcoming conference appearances, which will offer management the chance to discuss business trends. Despite a recent pullback, the stock has shown strong year-to-date and one-year returns, though it now trades below analyst targets. A significant valuation debate exists, with one narrative suggesting the stock is 423.2% overvalued at $18.27 compared to its current price of $95.59 and an analyst target of $130, driven by concerns over margin pressure and profitability.
Aehr Test Systems Soars Again on Latest Orders, Jefferies Eyes Big-Time Upside Ahead
Aehr Test Systems (NASDAQ: AEHR) has experienced a dramatic surge in its stock price in 2026, driven by new orders for its FOX-XP systems used in AI chip testing. The company's recent orders, particularly a $22 million follow-on order from a lead AI processor customer, reinforce its ability to meet ambitious fiscal year 2027 revenue guidance of $130 million to $150 million. While the stock's valuation reflects significant growth expectations, analysts like Jefferies see substantial upside, despite the stock's inherent volatility.
Aehr Test Systems to Participate in the Jefferies Semiconductor, IT Hardware & Communications Technology Conference on August 25, 2026
Aehr Test Systems will participate in the Jefferies Semiconductor, IT Hardware & Communications Technology Conference on August 25, 2026. President and CEO Gayn Erickson and CFO Chris Siu will host investor meetings to discuss Aehr's role in enabling next-generation semiconductor devices for AI, silicon carbide, and silicon photonics markets. The company expects significant growth from the increasing adoption of wafer-level and package-level test and burn-in solutions.
Aehr Test Systems: The FY2027 Rebound Is Real, But The Price Asks For Too Much
Aehr Test Systems (AEHR) is rated Sell with a $23 price target, suggesting a significant downside from its current $105.97. While the company projects a strong FY2027 rebound with $130-$150 million in revenue and 18-22% non-GAAP net income, these figures are not yet supported by durable GAAP cash earnings, and cash conversion and margin recovery remain unproven. The current valuation reflects overly optimistic outcomes compared to current guidance and fundamentals.
Aehr Test Systems to Participate in the Jefferies Semiconductor, IT Hardware & Communications Technology Conference on August 25, 2026
Aehr Test Systems (NASDAQ:AEHR) announced its participation in the Jefferies Semiconductor, IT Hardware & Communications Technology Conference on August 25, 2026, in Chicago. President and CEO Gayn Erickson and CFO Chris Siu will meet with investors to discuss the company's role in semiconductor device enablement for AI, silicon photonics, data centers, automotive, and industrial applications. Aehr expects significant growth from the increasing adoption of wafer-level and package-level test and burn-in solutions across these markets.
Aehr CEO and CFO will meet investors at a Chicago tech conference
Aehr Test Systems (NASDAQ: AEHR) announced its participation in the Jefferies Semiconductor, IT Hardware & Communications Technology Conference in Chicago on August 24-25, 2026. President and CEO Gayn Erickson and CFO Chris Siu will meet investors on August 25 to discuss the company's test and burn-in solutions for AI processors, silicon carbide, gallium nitride, and silicon photonics. The company anticipates significant growth from the increasing adoption of wafer-level and package-level test and burn-in across various markets.
Aehr Test Systems to Participate in the Jefferies Semiconductor, IT Hardware & Communications Technology Conference on August 25, 2026
Aehr Test Systems will be participating in the Jefferies Semiconductor, IT Hardware & Communications Technology Conference. The company's management will hold investor meetings at this event. The conference is scheduled for August 25, 2026.
Ninepoint Partners LP Makes New Investment in Aehr Test Systems $AEHR
Ninepoint Partners LP has acquired a new stake of 9,996 shares in Aehr Test Systems (NASDAQ:AEHR) during the second quarter, valued at approximately $960,000. Institutional investors now own 69.69% of the company, while insiders have recently sold shares totaling $13.83 million. Analysts generally maintain a "Buy" rating for AEHR, with an average price target of $136.67.
Aehr Test Systems Sinks 10%, Teradyne Falls 5%, FormFactor Drops 6%: What's Hitting These Semiconductor Test Equipment Stocks?
Shares of semiconductor test equipment companies like Aehr Test Systems, Teradyne, FormFactor, and Cohu are experiencing significant declines, with Aehr Test Systems leading the drop by 10%. This downturn is attributed to sector-wide profit-taking after substantial year-to-date gains, rather than company-specific catalysts or broader market issues, as evidenced by the much smaller decline in the SPDR S&P Semiconductor ETF. The selling appears concentrated on AI hardware winners, suggesting a rotation out of these high-performing stocks.
GSA Capital Partners LLP Takes $926,000 Position in Aehr Test Systems $AEHR
GSA Capital Partners LLP has acquired a new position in Aehr Test Systems, purchasing 9,639 shares valued at approximately $926,000. This comes as other institutional investors have also adjusted their holdings, with 69.69% of the stock owned by institutions. Despite significant insider selling totaling $13.8 million over the last three months, analysts maintain a "Buy" rating for AEHR with a consensus price target of $136.67.
Aehr Test Systems | 4: Statement of changes in beneficial ownership of securities-Officer ROGERS VERNON
This article reports a change in beneficial ownership of securities for Aehr Test Systems, specifically involving Officer Vernon Rogers. The filing is identified as a Form 4 statement.
Royal Bank of Canada Buys 7,968 Shares of Aehr Test Systems $AEHR
Royal Bank of Canada increased its stake in Aehr Test Systems (NASDAQ:AEHR) by 15.3% in the first quarter, acquiring an additional 7,968 shares, bringing its total holdings to 59,939 shares valued at $2.22 million. Institutional ownership of Aehr Test Systems is substantial at 69.69%, with Vanguard, Halter Ferguson Financial, and UBS also increasing their positions. Despite broad positive analyst sentiment with an average "Buy" rating and a target price of $136.67, insiders have sold a significant 109,475 shares worth $13.83 million in the past 90 days.
AEHR TEST SYSTEMS (AEHR) exec sells 5,994 shares; no 10b5-1 plan noted
Vernon Rogers, Executive VP of Sales & Marketing at AEHR Test Systems (AEHR), sold a total of 5,994 shares of common stock in August 2026 across three separate transactions. The sales occurred on August 14 and August 17, with prices ranging from $134.00 to $143.77 per share. Notably, the sales were not conducted under a Rule 10b5-1 trading plan, and a portion of the reported shares included unvested restricted stock units.
Aehr Test Systems Exec VP of Sales & Mktg. Sold Shares Worth Over $847K
Vernon Rogers, the Exec VP of Sales & Mktg. at Aehr Test Systems (AEHR), sold 5,994 shares of common stock in three separate transactions on August 14 and August 17, 2026. The sales, executed at an average price of $141.33 per share, totaled $847,217. Following these transactions, Rogers directly owns 186,232 shares.
Aehr Test Systems Slides as Profit-Taking Hits Recent AI-Driven Rally
Aehr Test Systems (AEHR) shares dropped 14.9% today, likely due to profit-taking following a recent rally driven by AI interest, despite the company reporting strong orders, backlog growth, and a positive fiscal 2027 outlook. The selloff occurred without new negative company-specific news. Insider trading data shows significant sales by executives, and institutional investors also made large moves in the stock.
Rice Hall James & Associates LLC Purchases Shares of 87,546 Aehr Test Systems $AEHR
Rice Hall James & Associates LLC recently acquired 87,546 shares of Aehr Test Systems (NASDAQ:AEHR) in the second quarter, a new position valued at approximately $8.41 million. Institutional investors collectively own 69.69% of the semiconductor company. Analyst sentiment is largely positive with a consensus "Buy" rating, despite recent insider share sales totaling over $13.8 million.
Is Aehr Test Systems (AEHR) Overvalued As Its Share Price Momentum Surges?
Aehr Test Systems (AEHR) has experienced significant share price momentum, rising 8.6% in one day and 80% over the past month, reaching $145.61. Despite this surge, a widely followed valuation narrative suggests the company is 697% overvalued, with a fair value pegged at $18.27, based on ambitious revenue forecasts and future earnings multiples. The article advises investors to scrutinize the underlying data and risks to form their own conclusions given the mixed opinions on its valuation.
AEHR (NASDAQ: AEHR) insider lines up new stock sale after $273K trade
AEHR insider Vernon I. Rogers has filed a Form 144 to sell 3,994 shares of common stock, valued at approximately $574,217.38, through Fidelity Brokerage Services LLC on August 17, 2026. This follows a previous sale of 2,000 shares for $273,000 on August 14, 2026. The filing also details multiple restricted stock vesting events that occurred in 2025 as part of his compensation.
Weekly Recap: Aehr Test Systems $22M wafer order and Jefferies $175 target
Aehr Test Systems (AEHR) secured a $22 million order for FOX-XP WLBI systems, WaferPak contactors, and Auto Aligners to test nine 300mm wafers for a Taiwanese high-volume partner, with shipments spanning six months. Simultaneously, Jefferies initiated coverage on AEHR with a $175 price target. This recap summarizes these two key financial developments for the company.
The Manufacturers Life Insurance Company Makes New Investment in Aehr Test Systems $AEHR
The Manufacturers Life Insurance Company recently acquired 7,856 shares of Aehr Test Systems (NASDAQ:AEHR), valued at approximately $291,000, amid strong AI-related demand benefiting the semiconductor company. While Aehr Test Systems is experiencing record bookings, a substantial backlog, and positive revenue guidance, concerns about its elevated valuation and insider selling pose potential risks. Analysts maintain a "Buy" rating with a consensus price target of $136.67.
Aehr Test Systems VP Alistair Sporck sells $108,490 in common stock
Alistair N Sporck, VP of Contactor Business Unit at Aehr Test Systems (NASDAQ:AEHR), sold 1,000 shares of common stock for $108,490. This transaction occurred on August 10, 2026, with each share priced at $108.49. Following the sale, Sporck still directly holds 22,547 shares and indirectly owns 5,177 shares through a trust, while the stock has seen a significant 632% return over the past year.
Penn Capital Management Company LLC Makes New Investment in Aehr Test Systems $AEHR
Penn Capital Management Company LLC has made a new investment in Aehr Test Systems (NASDAQ:AEHR), acquiring 150,547 shares worth approximately $14.5 million, giving it a 0.46% stake. Institutional investors now own 69.69% of the company, which has an average "Buy" rating and a $136.67 price target due to strong AI-related demand and record bookings. Despite positive analyst sentiment and robust orders, insider selling of 109,475 shares worth $13.8 million suggests some profit-taking.
Aehr Test Systems (NASDAQ:AEHR) Rating Increased to Strong-Buy at Jefferies Financial Group
Jefferies Financial Group has upgraded Aehr Test Systems (NASDAQ:AEHR) to a "strong-buy" rating, joining other analysts in a bullish outlook, with a consensus price target of $136.67. The company's stock opened at $134.06 and is near its 52-week high, supported by recent AI-related orders and strong bookings despite insider selling. Aehr Test Systems develops semiconductor test and burn-in equipment for integrated circuits, focusing on wafer-level reliability and functional testing.
Aehr test systems director Rhea Posedel sells $836,220 in stock
Aehr Test Systems director Rhea J. Posedel sold 5,973 shares of the company's common stock for a total of $836,220 on August 14, 2026. This transaction occurred near the stock's 52-week high after a significant surge in value. Following the sale, Posedel retains substantial direct and indirect holdings in the company.
Aehr Test Systems Insiders Sold Shares Worth Over $2M
Two insiders at Aehr Test Systems (AEHR) recently sold shares totaling over $2 million. Alberto Salamone, EVP of Ppbi Business, sold 9,672 shares for $1,235,287, and Director Howard T. Slayen sold shares worth $758,264. Both sales were reported through SEC Form 4 filings.
AWM Investment Company (AEHR) discloses 374,808-share, 1.1% position in AEHR
AWM Investment Company, Inc. has filed an amended Schedule 13G disclosing a beneficial ownership of 374,808 shares of AEHR Test Systems' common stock, representing 1.1% of the class. The shares are held across four Special Situations funds, with AWM exercising sole voting and dispositive power. This filing indicates that AWM's ownership is now 5% or less of AEHR's outstanding common stock.
Aehr Test Systems Soars Again Friday. Shares Now Up More than 500% On the Year.
Aehr Test Systems (NASDAQ:AEHR) shares rose significantly on Friday after Jefferies initiated coverage with a Buy rating and a $175 price target, highlighting the company's strong position in the semiconductor testing market driven by AI chip complexity. The stock is now up over 500% year-to-date, fueled by increasing demand for intensive testing of AI accelerators and the diversification of its revenue mix away from a single customer. Despite its impressive rally and industry tailwinds, the article cautions investors about extreme valuation risk due to the company's small market cap, lumpy revenue, high beta, and ongoing insider selling.
Aehr Test Systems surges after Jefferies initiates with bullish views
Aehr Test Systems (AEHR) saw its shares jump by about 10% on Friday after Jefferies initiated coverage of the company with a Buy rating. The investment bank set a price target of $175 for AEHR, highlighting the company's unique position as the sole vendor offering both wafer- and package-level testing solutions.
